Waiting now for the announcement which says the human clinical trial for asthma can go ahead, given the safety of Cymerus MSC's in humans as demonstrated by the results of the safety review board for the study into GvHD (expected in January).
Ann: Final Preclinical Asthma Study Confirms Efficacy, page-9
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $45.16M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 28.0¢ | 24.5¢ | $103.8K | 408.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 35587 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 7013 | 2 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |